Abstract:Our aim was to evaluate Bayesian Linear Regression (BLR) models with BayesC and BayesR priors as a fine mapping tool and compare them to the state-of-the-art external models: FINEMAP, SuSIE-RSS, SuSIE-Inf and FINEMAP-Inf. Based on extensive simulations, we evaluated the different models based on F classification score. The different models were applied on quantitative and binary UK Biobank (UKB) phenotypes and evaluated based upon predictive accuracy and features of credible sets (CSs). We used over 533K genotyped and 6.6 million imputed single nucleotide polymorphisms (SNPs) for simulations and UKB phenotypes respectively, from over 335K UKB White British Unrelated samples. We simulated phenotypes from low (GA1) to moderate (GA2) polygenicity, heritability ( ) of 10% and 30%, causal SNPs (π) of 0.1% and 1% sampled genome-wide, and disease prevalence (PV) of 5% and 15%. Single marker summary statistics and in-sample linkage disequilibrium were used to fit models in regions defined by lead SNPs. BayesR improved the F score, averaged across all simulations, between 27.26% and 13.32% relative to the external models. Predictive accuracy quantified as variance explained (R ), averaged across all the UKB quantitative phenotypes, with BayesR was decreased by 5.32% (SuSIE-Inf) and 3.71% (FINEMAP-Inf), and was increased by 7.93% (SuSIE-RSS) and 8.3% (BayesC). Area under the receiver operating characteristic curve averaged across all the UKB binary phenotypes, with BayesR was increased between 0.40% and 0.05% relative to the external models. SuSIE-RSS and BayesR, demonstrated the highest number of CSs, with BayesC and BayesR exhibiting the smallest average median size CSs in the UKB phenotypes. The BLR models performed similar to the external models. Specifically, BayesR’s performance closely aligned with SuSIE-Inf and FINEMAP-Inf models. Collectively, our findings from both simulations and application of the models in the UKB phenotypes support that the BLR models are efficient fine mapping tools.

A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis

Bayesian statistics in spatial epidemiology]

A bayesian multivariate mixture model for high throughput spatial transcriptomics

A Bayesian mark interaction model for analysis of tumor pathology images

Bayesian Inference Using the Proximal Mapping: Uncertainty Quantification Under Varying Dimensionality

A General Bayesian Functional Spatial Partitioning Method for Multiple Region Discovery Applied to Prostate Cancer MRI

High-dimensional Bayesian Model for Disease-Specific Gene Detection in Spatial Transcriptomics

A Bayesian Model for Spatial Partly Interval-Censored Data

Spatial extended hazard model with application to prostate cancer survival

CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses

Bayesian modeling of spatial molecular profiling data via Gaussian process

A Bayesian spatial model for imaging genetics

Bayesian Spatial Models for Voxel-wise Prostate Cancer Classification Using Multi-parametric MRI Data

Bayesian Landmark-based Shape Analysis of Tumor Pathology Images

Identifying clusters in Bayesian disease mapping

Is Seeing Believing? A Practitioner's Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies

Evaluation of Bayesian Linear Regression Models as a Fine Mapping tool

Detecting Disease-Associated Genomic Outcomes Using Constrained Mixture of Bayesian Hierarchical Models for Paired Data.

Bayesian Nonparametric Variable Selection as an Exploratory Tool for Finding Genes that Matter

Genomic Prediction Using Bayesian Regression Models With Global–Local Prior

A Bayes Factor Approach with Informative Prior for Rare Genetic Variant Analysis from Next Generation Sequencing Data